Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
Fibroblast growth factor receptor 3 (FGFR3) is expressed in squamous cell carcinoma of the head and neck (SCCHN) including oropharyngeal squamous cell carcinoma (OPSCC) and is a potential therapeutic target. However, information on its correlation with other relevant cancer related proteins stratifi...
Main Authors: | Sreenivas Nannapaneni, Christopher C Griffith, Kelly R Magliocca, Wanqi Chen, Xueying Lyu, Zhengjia Chen, Dongsheng Wang, Xu Wang, Dong M Shin, Zhuo G Chen, Nabil F Saba |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0247498 |
Similar Items
-
Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors
by: Guoming Hu, et al.
Published: (2018-11-01) -
Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.
by: Shalom Madar, et al.
Published: (2013-01-01) -
P53 Mutant p53N236S Regulates Cancer-Associated Fibroblasts Properties Through Stat3 Pathway
by: Liu Q, et al.
Published: (2020-02-01) -
p53 and FBXW7: Sometimes Two Guardians Are Worse than One
by: María Galindo-Moreno, et al.
Published: (2020-04-01) -
Worse and Worse and Worse: Essential Tremor Patients’ Longitudinal Perspectives on their Condition
by: Jesus Gutierrez, et al.
Published: (2016-10-01)